I don’t have live access to current news in this moment, but here’s what I can share based on recent public health updates up to 2025.
Direct answer
- There have been reports in 2024–2025 of Orthoebolavirus zairense (EBOV) outbreaks in sub-Saharan Africa, with treatment and vaccine efforts highlighted by public health partners, including emergency response in parts of the DRC. For the latest, please check trusted sources such as the WHO, CDC, and major health news outlets.
Context and key points
- Orthoebolavirus zairense is the species more commonly referred to as Ebola virus; ongoing outbreaks have driven rapid deployment of therapeutics and vaccines in affected regions.[1][2][3]
- Treatments authorized or in use during recent outbreaks include monoclonal antibodies and antiviral regimens, with programs often coordinated by national ministries of health and international partners to provide access to care in affected areas.[2][1]
- Public health authorities emphasize transmission through bodily fluids, the importance of rapid diagnosis, isolation of suspected cases, contact tracing, and community engagement to curb spread.[5][1]
What to look for in latest news
- Outbreak status: current number of cases and deaths, geographic area, and whether transmission is ongoing.
- Treatments and vaccines: which products are being used, eligibility (adults, children, neonates), and any new approvals or stockpiling updates.
- Public health response: updates from the DRC Ministry of Health, WHO situation reports, and international partnerships.
If you’d like, I can search for the latest news now and summarize the most recent developments with citations. I can also tailor the briefing to your location (Miami) and any travel or caregiving needs.
Sources
Inmazeb ® (atoltivimab, maftivimab, and odesivimab-ebgn) was the first treatment approved by the U.S. Food and Drug Administration (FDA) for Orthoebolavirus zairense , also known as Zaire ebolavirus Supply is being rushed to Democratic Republic of Congo (DRC) to help with the current outbreak
newsroom.regeneron.comRecent outbreaks of Marburg virus disease in regions of sub-Saharan Africa without prior record such as Ghana, Tanzania, Equatorial Guinea, and Rwanda challenge the current understanding of areas at-risk for filovirus spillover. The ...
pmc.ncbi.nlm.nih.govAbstractBackground. Ebola (EBOV) and Sudan (SUDV) orthoebolaviruses are responsible for lethal hemorrhagic fever outbreaks in humans in Central and West Af
academic.oup.com/PRNewswire/ -- The Minister of Health from the Democratic Republic of the Congo (DRC) has declared an outbreak of Ebola virus disease (EVD) in Kasai Province...
www.prnewswire.comAs the high pathogenic species of Filoviridae virus family, Orthoebolavirus zairense (EBOV) shows frequent outbreaks in human in recently years since its first emerging in 1976 in Democratic Republic of the Congo (COD), bringing ongoing risks and burden on public health safety. Here, the phylogeneti …
pubmed.ncbi.nlm.nih.govWe develop and test a risk map for Orthoebolaviruses which are emerging infectious pathogens primarily concentrated in sub-Saharan Africa. The accuracy of predictive models and risk maps has been limited thus far by uncertainty in mechanisms ...
pmc.ncbi.nlm.nih.govOrthoebolavirus zairense es un especie
ecuador.inaturalist.orgPer CDCKey points • Ebola disease is caused by an infection with an orthoebolavirus. • Orthoebolaviruses are found primarily in sub-Saharan Africa. • Orthoebolaviruses can cause serious and often deadly disease, with a mortality rate as high as 80 to 90 percent. • There is an FDA-approved vaccine for the prevention of Ebola virus (species Orthoebolavirus zairense).TypesThere are four orthoebolaviruses that cause illness in people: • Ebola virus (species Orthoebolavirus zairense) causes Ebola vir
www.bchealthdept.orgspecies of virus
www.wikidata.org